PGE2 as a baddie during influenza infection

One of the things that bugs me a lot, in an entirely geeky way, is when people tell me they have the flu - most of the time, they really just have a cold, caused by a completely different pathogen. Influenza, the real cause of flu, can actually cause very serious disease, much more debilitating than a cold virus, and can even lead to death. Case in point: the Spanish flu is thought to have killed more than 20 million people during the first world war, many believe that was responsible for more deaths than the war itself.

Villains
Image from
https://www.flickr.com/photos/kaptainkobold/6900425981/

But I digress. The rant was triggered by a very interesting paper that I spotted in this week's Immunity, which identified a new potential therapeutic target for influenza A: a group of molecules known as prostaglandins.

An involvement for prostaglandins, a group of lipid molecules with many roles including inflammation and immunity, in influenza infection is not new. A quick search in PubMed revealed that members of the prostaglandin family have previously been shown to block influenza replication and limit inflammation, and deficiency in the enzymes responsible for generating the prostaglandin PGE2 (COX1 and COX2) has revealed conflicting results.

Serpins offer survival advantage to metastatic cancer cells

Cancer cells manage to get away with a lot - they evade recognition by cells of the immune system, they hijack oxygen and nutrients from normal cells and tissues, and travel and successfully establish themselves into new parts of the body. The later, known as metastasis, is considered the main cause of death in cancer, and despite this the factors driving it have remained fairly enigmatic. But today I came across a slightly older study from Cell that identified a  'duel' between cancer cells and cells from the brain microenvironment involving the molecule plasmin.

Plasmin is an enzyme that is released by the body to break down naturally occurring blood clots, and in the brain is expressed in high levels by one type of cell known as an astrocyte. While looking for factors involved in metastasis, the authors of this study found that metastatic lung and breast cancer cells express high levels of molecules known as serpins, a subset of which (NS, serpin B2, serpin E1 and serpin E2) are known to inhibit the function of plasmin.

Its good to talk, especially in the case of fat cells and skin cells

To get anywhere, you need effective communication, be it between say construction workers building a bridge (as a human example), worker bees making honey or bats out in the dark hunting for food. The same applies in the micro scale - the cells in our body need to communicate at different stages of development so that they know what to become, where to go, whether to grow or die, among other things.

Its good to talk.
 Image from https://www.flickr.com/photos/danielcoy/4175199668

And just like many other cells in the body, adipocytes (or fat cells; a slight obsession of mine in my previous life!) communicate with a type of skin cell known as a keratinocyte, sending signals to regulate the growth of hair follicles and, ultimately, hair growth (a very complicated cycle of growth and death that you can read about here if you have access). It turns out that this line of communication actually goes both ways, as a new study published in PNAS shows that molecular signals from epidermal cells also regulate the growth of the underlying adipocyte layer.

CMPF could offer a new target for diabetes

A potential culprit for diabetes in pregnancy (gestational diabetes) and type 2 diabetes has been identified in a recent study published in Cell Metabolism.

Gestational diabetes can affect up to 5% of pregnant women, at least in the UK, and can develop in the absence of any previous history of intolerance to glucose. Women with this condition have higher than normal levels of glucose in their blood, usually because their bodies do not produce enough insulin to transport glucose into the cells. The mechanism underlying the development of this condition has remained a mystery, although it has been linked with a decline in the function of pancreatic β cells, the cells that produce insulin.

An imbalance of metabolites

When the authors screened the blood plasma of women with gestational diabetes, they found a significant change in metabolites compared with women without this disease, in particular in the levels of a range of fatty acids. Among this was the furan fatty acid metabolite CMPF, which was greatly increased in those with gestational diabetes. Interestingly, levels of CMPF were also increased in patients with type 2 diabetes compared with controls, and in both cases this was independent of BMI or age.